Rua sales are growing rapidly

Monthly sales revenue has increased 5x over three months

Rua is seeking cash to fund rapid sales growth

We have established strong sales pipelines in three key markets—Germany, Australia, and New Zealand—and expect to expand to a fourth, the United Kingdom, by the end of 2024. We require further capital to sustain the growth.

Through continued shareholder support this will provide the funds needed for working capital, including crop cultivation and service purchases, and to support our short-term cash flow.

Existing Rua Bioscience shareholders are invited to participate in this offer. For every 4 shares you hold, you are eligible to purchase an additional 3 new shares. New investors are welcome to apply for any available shortfall shares.

Explore the documents and details below for more information.

Our vision and purpose

Click on the button below to view the documents.

Where do I go and how do I participate?

EXISTING SHAREHOLDER

WITH

Computershare

EXISTING SHAREHOLDER

WITH

Sharesies

Or alternatively go to your Sharesies app, find Rua, and follow the instructions.

NEW SHAREHOLDER

GO TO

Sharesies

Or go to your Sharesies app and search for Rua.

Useful links

Investor presentation with commentary from CEO, Paul Naske - link

Webinar on Rua with co-founder Panapa Ehau, Porourangi Tawhiwhirangi and Paul Naske - link

Sharesies podcast interview with Paul Naske - link

Frequently asked questions

  • Rua requires further capital to fund the growth of its business.  The funds raised through the Rights Offer will be used to meet its immediate cashflow requirements and support Rua’s growth plans, including international market expansion and product development.  This will strengthen the company's financial position and provide working capital which is required for growth. 

  • Up to $3.1m.

  • Follow the instructions at www.shareoffer.co.nz/rua 

  • You will need to visit Sharesies.  You will be able to purchase shares through their platform if there is a sufficient shortfall in subscriptions under the Rights Offer.

  • All investing involves risk—you aren’t guaranteed to make money, and you might lose the money you start with.

    We encourage you to do your due diligence, consider the risks involved, and speak to a licensed financial advice provider if you need help deciding whether to take part.

  • A Renounceable Rights Offer gives current Rua Bioscience shareholders the right to buy additional new shares in the company (New Shares) at a discounted price. If they do not want to purchase additional New Shares, they can give up or “renounce” their right to it, and in fact sell these rights. These rights can be traded or sold on the stock exchange between 12 November and 20 November under the ticker RUARA. You will need to instruct your broker or an NZX Firm to sell your rights, such as Sharesies. 

    In summary, if you are already a shareholder, you have a right to buy more New Shares under the Rights Offer or sell the rights to someone else.  

  • There are different ways to raise capital, but a common way is to issue new shares through a placement or a rights offer.  A rights offer is considered the fairest way as it gives all shareholders the chance to participate on the same terms.

    Rua Bioscience currently has approximately 164 million shares and plans to issue another 122 million shares (approximately) through the rights offer and any shortfall placement.  

    For every 4 shares you currently own in Rua, you will be allowed to purchase another 3 New Shares for 2.5 cents a share.   This means you will have a “Right” to 3 New Shares for every 4 you own.  

    For example, if you own 10,000 shares you will receive 7,500 rights giving you the ability to subscribe for up to 7,500 New Shares for an aggregate subscription price of $187.50.   

    Under the example above, you can either: 

    1. take up all or some of your Rights (i.e. buy some or all of the 7,500 New Shares up to $187.50); or  

    1. take up all of your Rights and apply for Additional New Shares as a part of the Oversubscription Facility (i.e. buy the full 7,500 New Shares for $187.50 and apply for more New Shares at the same price of 2.5 cents per share); or 

    1. sell all or some of your Rights on the NZX Main Board (i.e. don’t buy any New Shares but sell your Right to someone else); or 

    1. take up some of your Rights, and sell all or some of the remaining balance on the NZX Main Board (i.e. buy some New Shares and sell some of your Rights); or 

    1. do nothing with all or some of your Rights. 

  • By participating, you can: 

    - Buy additional shares in Rua Bioscience at a lower price than the current market value. 

    - Increase your overall shareholding in the company. 

    - Avoid dilution of your existing shareholding (your percentage ownership of RUA won’t decrease if you subscribe in full). 

Details

  • See the Section Important Dates in the Offer Document.

    BUT Closing Date of the Offer is Monday 2nd December.

  • If you don’t want to buy more shares, you can sell your rights during the trading period (12 -20 November). Alternatively, if you do nothing, your rights will lapse, and you won’t be required to do anything, but your shareholding will likely be diluted

  • Yes, since this is a renounceable offer, your rights can be sold on the stock exchange. You can trade these rights like shares, so if you don’t want to participate, you have the option to sell them to others. 

  • If you sell your rights, the buyer of those rights will have the option to purchase the additional New Shares at the discounted price. You will receive the proceeds from selling your rights. 

  • Payment details will be specified at www.shareoffer.co.nz/rua or through your Sharesies app.

  • In the offer document, Sharesies are called a “Custodian”.   

    If you hold your shares through Sharesies they will notify you directly of the rights you are entitled to. You will need to follow their process to either take up the offer or sell your rights.  They should have sent you details via email.  If you have not received an email from them, contact them through the Sharesies app or help@sharesies.co.nz.

  • Participation in the Rights Offer is not compulsory. However, if you do not participate, your shareholding will be diluted. This means your percentage ownership in Rua Bioscience will decrease as more shares are sold to others. 

  • Yes, you can. You apply on the www.shareoffer.co.nz/rua web page and, if there are shares available you can buy more.   

More help

  • Computershare web page – www.shareoffer.co.nz/rua  

    Email Rua on info@ruabio.com if you have any questions.  

  • If you have any doubts or need further clarification, it's a good idea to speak to a financial advisor.